SOD2 and breast carcinoma: Therefore, we conducted a population-based case-control study among women treated with cyclophosphamide-based chemotherapy (cyclophosphamide-epirubicin-5-fluorouracil – CEF) in Denmark to evaluate the effect of the SOD2 polymorphism on breast cancer recurrence.